Prostate Cancer

Latest News

Genetic Variants Show ‘Potential’ to Identify High-Risk Prostate Cancer | Image Credit: © Dr_Microbe -
Genetic Variants Show ‘Potential’ to Identify High-Risk Prostate Cancer

March 21st 2023

A genetic analysis indicates that multi-ancestry polygenic risk scores may be “potentially useful” in detecting risk of aggressive prostate cancer in patients of African ancestry, according to an expert from the University of Southern California.

Enzalutamide plus leuprolide appears to improve metastases-free survival vs placebo plus leuprolide in patients with non-metastatic hormone-sensitive prostate cancer.
Enzalutamide/Leuprolide Improves MFS in Prostate Cancer Subtype

March 20th 2023

Use of a kit that prepares for gallium Ga 68 gozetotide injection in the phase 3 VISION study affirms its ability to identify patients who suitable to receive PSMA-based radioligand for metastatic prostate cancer.
FDA Expands Indication for Illuccix for PSMA Radioligand Selection in Prostate Cancer

March 16th 2023

Anthony D’Amico, MD, PhD, reviewed current practices and unanswered questions surrounding radiotherapy in the realm of prostate cancer.
Expert Dissects Recent Research into Radiotherapy for Prostate Cancer

March 15th 2023

Matthew Dallos, MD, discusses current challenges in the treatment of castration-resistant prostate cancer and the potential of antibody-drug conjugates in this disease space.
Expert Charts the Changing Treatment Landscape in CRPC

March 14th 2023

More News